Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CONFORMIS, INC.

(CFMS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Conformis : Settles Patent Lawsuit With Stryker Corporation

07/07/2021 | 08:49am EDT


ę MT Newswires 2021
All news about CONFORMIS, INC.
02:49pCONFORMIS : Warns on Q3 Sales as COVID-19 Delays Surgeries; Shares Sag
MT
09/20Health Care Stocks Sink with Broader Markets
MT
09/20CONFORMIS : Cuts Q3 Product Revenue Outlook Following Higher Levels of Rescheduled, Deferr..
MT
09/20CONFORMIS : Business Update Provided in Advance of the Oppenheimer Fall Healthcare Life Sc..
PU
09/20CONFORMIS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/20Conformis, Inc. Provides Business Update
GL
09/07Conformis, Inc. to Participate in Upcoming Investor Conferences
GL
08/18CONFORMIS : Announces First Procedure Performed Using the Identity Imprint™ Knee Rep..
AQ
08/18Conformis, Inc. Announces First Procedure Performed Using the Identity ImprintÖ Knee Re..
CI
08/05CONFORMIS : Swings to Q2 Profit as Revenue Climbs; Shares Rise Pre-Bell
MT
More news
Financials (USD)
Sales 2021 95,0 M - -
Net income 2021 1,87 M - -
Net cash 2021 86,4 M - -
P/E ratio 2021 221x
Yield 2021 -
Capitalization 316 M 316 M -
EV / Sales 2021 2,42x
EV / Sales 2022 3,15x
Nbr of Employees 259
Free-Float 95,7%
Chart CONFORMIS, INC.
Duration : Period :
Conformis, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CONFORMIS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 1,70 $
Average target price 2,33 $
Spread / Average Target 37,3%
EPS Revisions
Managers and Directors
Mark A. Augusti President, Chief Executive Officer & Director
Robert Howe CFO, Treasurer & Principal Accounting Officer
Kenneth P. Fallon Chairman
Marc Quartulli Vice President-Clinical Affairs & Market Access
Gary Maingot Senior Vice President-Operations
Sector and Competitors